Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Myers

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Clinical Neuropharmacology|April 1, 1987
The use of cyclophosphamide to treat multiple sclerosisL W Myers
Current Neurology and Neuroscience Reports|March 20, 2002
Immunologic therapy for secondary and primary progressive multiple sclerosisL W Myers
Bulletin of the Los Angeles Neurological Societies|July 1, 1970
Delayed hypersensitivity and the nervous system. A review of in vitro studies of delayed hypersensitivity and their application to neurological diseasesL W Myers
Neurology|July 1, 1980
Immunosuppressive drugs in multiple sclerosis: pro and conG W Ellison, L W Myers
Behaviour Research and Therapy|January 1, 1976
Extinction effects following interpolation of instrumental trials among response prevention periodsJ J Franchina, L W Myers
Epilepsy Research. Supplement|January 1, 1996
Polypharmacy in multiple sclerosisL W Myers, J T Phillips
Neurologic Clinics|February 1, 1990
The peculiar difficulties of therapeutic trials for multiple sclerosisL W Myers, G W Ellison
Neurology|September 1, 1978
A review of systemic nonspecific immunosuppressive treatment of multiple sclerosisG W Ellison, L W Myers
Annals of the New York Academy of Sciences|January 1, 1984
Cytotoxic cells in peripheral blood and cerebrospinal fluid of multiple sclerosis patientsJ E Merrill, L W Myers, G W Ellison
Clinical Immunology and Immunopathology|June 1, 1984
Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases: analysis at the single cell level of the relationship of cytotoxic effectors and interferon-producing cellsJ E Merrill, G W Ellison, L W Myers
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Clinical Neuropharmacology|April 1, 1987
The use of cyclophosphamide to treat multiple sclerosisL W Myers
Current Neurology and Neuroscience Reports|March 20, 2002
Immunologic therapy for secondary and primary progressive multiple sclerosisL W Myers
Bulletin of the Los Angeles Neurological Societies|July 1, 1970
Delayed hypersensitivity and the nervous system. A review of in vitro studies of delayed hypersensitivity and their application to neurological diseasesL W Myers
Neurology|July 1, 1980
Immunosuppressive drugs in multiple sclerosis: pro and conG W Ellison, L W Myers
Behaviour Research and Therapy|January 1, 1976
Extinction effects following interpolation of instrumental trials among response prevention periodsJ J Franchina, L W Myers
Epilepsy Research. Supplement|January 1, 1996
Polypharmacy in multiple sclerosisL W Myers, J T Phillips
Neurologic Clinics|February 1, 1990
The peculiar difficulties of therapeutic trials for multiple sclerosisL W Myers, G W Ellison
Neurology|September 1, 1978
A review of systemic nonspecific immunosuppressive treatment of multiple sclerosisG W Ellison, L W Myers
Annals of the New York Academy of Sciences|January 1, 1984
Cytotoxic cells in peripheral blood and cerebrospinal fluid of multiple sclerosis patientsJ E Merrill, L W Myers, G W Ellison
Clinical Immunology and Immunopathology|June 1, 1984
Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases: analysis at the single cell level of the relationship of cytotoxic effectors and interferon-producing cellsJ E Merrill, G W Ellison, L W Myers
Pageof 8